{
    "organizations": [],
    "uuid": "39d00cdb45d7139a5c7a9a3bdd273e43af268a33",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-zhongxin-pharmaceutical-an/brief-tianjin-zhongxin-pharmaceutical-announces-investment-product-agreements-with-china-bohai-bank-idUSFWN1P30EO",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Zhongxin Pharmaceutical Announces Investment Product Agreements With China Bohai Bank",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd:\n* ‍SIGNED AGREEMENT WITH CHINA BOHAI BANK ,TIANJIN BRANCH, TO INVEST RMB150 MILLION IN CAPITAL-PROTECTED INVESTMENT PRODUCT​\n* ‍SIGNED AGREEMENT WITH CHINA BOHAI BANK CO TO INVEST A SUM OF RMB250 MILLION​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T17:50:00.000+02:00",
    "crawled": "2018-01-09T16:51:56.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tianjin",
        "zhongxin",
        "pharmaceutical",
        "group",
        "corp",
        "ltd",
        "agreement",
        "china",
        "bohai",
        "bank",
        "tianjin",
        "branch",
        "invest",
        "rmb150",
        "million",
        "investment",
        "agreement",
        "china",
        "bohai",
        "bank",
        "co",
        "invest",
        "sum",
        "rmb250",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}